Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Salivary Gland Neoplasms 1Recurrence 1Neoplasms 1Neoplasm Metastasis 1

Interventions

Radiotherapy, Conformal 2Fluorodeoxyglucose F18 2selinexor 1sargramostim 1fluoromisonidazole 1aldesleukin 1Taxes 1Surveys and Questionnaires 1Rubidium-82 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Polymerase Chain Reaction 1Oral Hygiene 1Moxibustion 1Mitogen-Activated Protein Kinase Kinases 1Magnetic Resonance Spectroscopy 1Lysine 1Liquid Biopsy 1Interleukin-12 Subunit p35 1Immunologic Techniques 1Gene Expression Profiling 1Gefitinib 1Electroacupuncture 1Biopsy 1Androgen Antagonists 1Acupuncture Therapy 15-fluoropentyl-2-methylmalonic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Salivary Gland Neoplasms × Mitogen-Activated Protein Kinase Kinases × Clear all
NCT02069730 2026-01-08

A Study of Drug Therapies for Salivary Gland Cancers Based on Testing of Genes

University Health Network, Toronto

Phase NA Completed
114 enrolled
Head & Neck

Neoplasm Metastasis, Neoplasms, Recurrence, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡